PNC Financial Services Group’s Clearside Biomedical CLSD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-7,194
| Closed | -$28.6K | – | 5188 |
|
|
2025
Q3 | $28.6K | Sell |
7,194
-1
| -0% | -$7 | ﹤0.01% | 3487 |
|
|
2025
Q2 | $86.3K | Hold |
7,195
| – | – | ﹤0.01% | 2808 |
|
|
2025
Q1 | $99.1K | Sell |
7,195
-21
| -0.3% | -$302 | ﹤0.01% | 2667 |
|
|
2024
Q4 | $103K | Buy |
7,216
+21
| +0.3% | +$345 | ﹤0.01% | 2664 |
|
|
2024
Q3 | $137K | Buy |
7,195
+6,823
| +1,834% | +$116K | ﹤0.01% | 2470 |
|
|
2024
Q2 | $7.26K | Hold |
372
| – | – | ﹤0.01% | 3889 |
|
|
2024
Q1 | $8.55K | Hold |
372
| – | – | ﹤0.01% | 3805 |
|
|
2023
Q4 | $6.54K | Hold |
372
| – | – | ﹤0.01% | 3866 |
|
|
2023
Q3 | $4.86K | Hold |
372
| – | – | ﹤0.01% | 4003 |
|
|
2023
Q2 | $6.26K | Hold |
372
| – | – | ﹤0.01% | 4048 |
|
|
2023
Q1 | $5.81K | Hold |
372
| – | – | ﹤0.01% | 3990 |
|
|
2022
Q4 | $6.26K | Hold |
372
| – | – | ﹤0.01% | 3920 |
|
|
2022
Q3 | $6K | Hold |
372
| – | – | ﹤0.01% | 3912 |
|
|
2022
Q2 | $8K | Hold |
372
| – | – | ﹤0.01% | 3873 |
|
|
2022
Q1 | $13K | Hold |
372
| – | – | ﹤0.01% | 3749 |
|
|
2021
Q4 | $15K | Hold |
372
| – | – | ﹤0.01% | 3652 |
|
|
2021
Q3 | $34K | Hold |
372
| – | – | ﹤0.01% | 3273 |
|
|
2021
Q2 | $27K | Hold |
372
| – | – | ﹤0.01% | 3350 |
|
|
2021
Q1 | $14K | Hold |
372
| – | – | ﹤0.01% | 3534 |
|
|
2020
Q4 | $15K | Hold |
372
| – | – | ﹤0.01% | 3439 |
|
|
2020
Q3 | $9K | Buy |
+372
| New | +$9.61K | ﹤0.01% | 3526 |
|
|
2018
Q3 | – | Sell |
-80
| Closed | -$13K | – | 4123 |
|
|
2018
Q2 | $13K | Buy |
+80
| New | +$13.5K | ﹤0.01% | 3595 |
|
Other funds holding CLSD
PNC Financial Services Group's CLSD Position: Q4 2025 in Review
PNC Financial Services Group sold out of Clearside Biomedical (CLSD) in Q4 2025, closing a stake of 7,194 shares — an estimated $28.6K sold.
PNC Financial Services Group first reported a position in CLSD in Q2 2018 and held it in 22 quarters. The position peaked at $137K in Q3 2024. 1 fund tracked by Wall St. Rank holds CLSD as of Q4 2025.
- PNC Financial Services Group reported no remaining Clearside Biomedical position as of Q4 2025 after selling out during the quarter.
- PNC Financial Services Group sold 7,194 Clearside Biomedical shares in Q4 2025, an estimated $28.6K.
- PNC Financial Services Group first reported a position in Clearside Biomedical in Q2 2018 and held it in 22 quarters.
- PNC Financial Services Group's Clearside Biomedical position peaked at $137K in Q3 2024.
- 1 fund tracked by Wall St. Rank held Clearside Biomedical as of Q4 2025.
Based on PNC Financial Services Group's 13F filing for Q4 2025, filed 6 Feb 2026.